Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-03

Clinical Trial Update: Investigating Real-Time Immunotherapy Symptoms Study [NA]

View source ↗

Summary

University of Pittsburgh is sponsoring a clinical trial to study real-time immunotherapy symptom monitoring, currently not yet recruiting, for melanoma (skin ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Pittsburgh | Conditions: Cancer, Melanoma (Skin Cancer) | NA | Status: NOT_YET_RECRUITING